Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $2
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and lowers the price target from $3.5 to $2.
Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and lowers the price target from $3.5 to $2.